Immunotherapy for Infectious Diseases

ix
Contributors
CONSTANTIN A. BONA, MD, PhD • Department of Microbiology, Mount Sinai
School of Medicine, New York, NY
PROSPER N. BOYAKA, PhD • Immunobiology Vaccine Center, University of
Alabama at Birmingham, Birmingham, AL
R. PAT BUCY, MD, PhD • Department of Pathology, University of Alabama at
Birmingham, Birmingham, AL
ARTURO CASADEVALL, MD, PhD • Department of Microbiology and Immunology,
Albert Einstein College of Medicine, Bronx, NY
ELIZABETH CONNICK, MD • Division of Infectious Diseases, University of Colorado
Health Sciences Center, Denver, CO
SAM T. DONTA, MD • Department of Medicine, Divisions of Infectious Diseases
and Biomolecular Medicine, Boston University School of Medicine, Boston, MA
RALPH DORNBURG, PhD • Division of Infectious Diseases, Jefferson Medical
College, Philadelphia, PA
EDGAR G. ENGLEMAN, MD • Stanford Blood Center, Palo Alto, CA
LAWRENCE M. FOX, MD, PhD • HIV Research Branch, Division of AIDS NIAID,
NIH, Bethesda, MD
PAUL GOEPFERT, MD • Department of Pathology, University of Alabama
at Birmingham, Birmingham, AL
HELEN HESLOP, MD • Departments of Medicine, Pediatrics, and Center for Cell
and Gene Therapy, Baylor College of Medicine, Houston, TX
JEFFREY M. JACOBSON, MD • AIDS Center, Mount Sinai School of Medicine,
New York, NY
JOHN L. JOHNSON, MD • Case Western Reserve University School of Medicine,
Division of Infectious Diseases, Cleveland, OH
SPYROS A. KALAMS, MD • Partners AIDS Research Center, Massachusetts
General Hospital, Charlestown, MA
HERMANN KATINGER, PhD • Institute of Applied Microbiology, University for
Agricultural Sciences, Vienna, Austria
J. MICHAEL KILBY, MD • Department of Pathology, University of Alabama at
Birmingham, Birmingham, AL
SMRITI K. KUNDU-RAYCHAUDHURI, MD • Division of Infectious Diseases,
Department of Medicine, Stanford University, Stanford, CA
RENATE KUNERT, PhD • Institute of Applied Microbiology, University for
Agricultural Sciences, Vienna, Austria